The stock price of Veracyte Inc (NASDAQ: VCYT) has plunged by -4.44 when compared to previous closing price of 27.93, but the company has seen a -1.07% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-05-28 that SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $VCYT–Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance Prostate and Bladder Cancer Research.
Is It Worth Investing in Veracyte Inc (NASDAQ: VCYT) Right Now?
Veracyte Inc (NASDAQ: VCYT) has a higher price-to-earnings ratio of 63.62x compared to its average ratio. VCYT has 36-month beta value of 2.10. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 1 as “sell.”
The public float for VCYT is 77.23M, and currently, short sellers hold a 7.08% ratio of that float. The average trading volume of VCYT on June 13, 2025 was 1.00M shares.
VCYT’s Market Performance
The stock of Veracyte Inc (VCYT) has seen a -1.07% decrease in the past week, with a -8.94% drop in the past month, and a -12.29% fall in the past quarter. The volatility ratio for the week is 2.62%, and the volatility levels for the past 30 days are at 2.21% for VCYT. The simple moving average for the last 20 days is -3.17% for VCYT stock, with a simple moving average of -23.92% for the last 200 days.
Analysts’ Opinion of VCYT
Many brokerage firms have already submitted their reports for VCYT stocks, with Craig Hallum repeating the rating for VCYT by listing it as a “Buy.” The predicted price for VCYT in the upcoming period, according to Craig Hallum is $45 based on the research report published on March 20, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see VCYT reach a price target of $37, previously predicting the price at $38. The rating they have provided for VCYT stocks is “Neutral” according to the report published on December 05th, 2024.
Wolfe Research gave a rating of “Outperform” to VCYT, setting the target price at $50 in the report published on November 15th of the previous year.
VCYT Trading at -9.33% from the 50-Day Moving Average
After a stumble in the market that brought VCYT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.59% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VCYT starting from Leite John, who sale 2,809 shares at the price of $27.20 back on Jun 04 ’25. After this action, Leite John now owns 94,540 shares of Veracyte Inc, valued at $76,410 using the latest closing price.
JOHN LEITE, the Officer of Veracyte Inc, proposed sale 2,809 shares at $26.50 during a trade that took place back on Jun 04 ’25, which means that JOHN LEITE is holding shares at $74,438 based on the most recent closing price.
Stock Fundamentals for VCYT
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.68 for the gross margin
The net margin for Veracyte Inc stands at 0.07. The total capital return value is set at 0.02. Equity return is now at value 2.86, with 2.63 for asset returns.
Based on Veracyte Inc (VCYT), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 1.77. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is 11901.0.
Currently, EBITDA for the company is 49.2 million with net debt to EBITDA at -2.71. When we switch over and look at the enterprise to sales, we see a ratio of 4.22. The receivables turnover for the company is 8.62for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.10.
Conclusion
To put it simply, Veracyte Inc (VCYT) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
